Franklin Resources
SRNE

Franklin Resources’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Franklin Resources’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-289,400
Closed -$1.14M – 1544
2017
Q1 		$1.14M Sell
289,400
-50,000
-15% -$251K ﹤0.01% 1308
2016
Q4 		$1.66M Hold
339,400
– – ﹤0.01% 1262
2016
Q3 		$2.63M Hold
339,400
– – ﹤0.01% 1213
2016
Q2 		$1.9M Hold
339,400
– – ﹤0.01% 1255
2016
Q1 		$1.83M Hold
339,400
– – ﹤0.01% 1264
2015
Q4 		$2.96M Hold
339,400
– – ﹤0.01% 1231
2015
Q3 		$2.85M Hold
339,400
– – ﹤0.01% 1236
2015
Q2 		$5.98M Buy
+339,400
New +$4.36M ﹤0.01% 1146

Other funds holding SRNE

WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Franklin Resources's SRNE Position: Q2 2017 in Review

Franklin Resources sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2017, closing a stake of 289,400 shares — an estimated $1.14M sold.

Franklin Resources first reported a position in SRNE in Q2 2015 and held it in 8 quarters. The position peaked at $5.98M in Q2 2015. 46 funds tracked by Wall St. Rank hold SRNE as of Q2 2017.

  • Franklin Resources reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Franklin Resources sold 289,400 Sorrento Therapeutics, Inc. shares in Q2 2017, an estimated $1.14M.
  • Franklin Resources first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 8 quarters.
  • Franklin Resources's Sorrento Therapeutics, Inc. position peaked at $5.98M in Q2 2015.
  • 46 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2017.

Based on Franklin Resources's 13F filing for Q2 2017, filed 10 Aug 2017.